Vascular surgeons order compression therapy devices for patients recovering from surgery or managing chronic venous disease. Wound-care clinicians and physiotherapists prescribe them for lymphedema and slow-healing wounds. Hospital nursing staff apply them as routine DVT prophylaxis on admitted patients, and beyond the clinic, patients buy compression stockings and wraps directly to manage swelling and vein disease at home. The category itself is simple: graduated compression stockings, multi-layer bandaging systems, adhesive compression tapes, and programmable pneumatic compression pumps that inflate and deflate on a set cycle to push venous blood back toward the heart.
Contrive Datum Insights values this market at USD 4.41 billion in 2025, rising to USD 4.79 billion in 2026 and to USD 9.34 billion by 2034, a compound annual growth rate of 8.71% across the forecast window. Venous disorders and DVT prophylaxis together account for 39.91% of 2025 revenue (USD 1.76 billion), the largest of the indication categories the report tracks, and rising diagnosis rates alongside more standing prophylaxis orders are the single largest contributor to growth through 2034.
Spending Moves Toward Programmable Devices, and Toward Asia Pacific
Not every dollar in this market grows at the same speed. Static compression, the stockings, bandages and wraps that require no device, still accounts for most of the spending: 58.4% of 2025 revenue, USD 2.58 billion. Its own growth rate of 7.34% a year trails the market average, and its share is projected to slip to 52% by 2034. Dynamic compression, the pneumatic pump category, is smaller today at 36.6% of revenue but compounds at 10.64%, carrying its value from USD 1.61 billion to USD 4.02 billion and its share to 43%. The pattern repeats one level down: compression stockings lead 2025 product revenue at 34.01% (USD 1.5 billion) while pumps grow fastest of any product line at 12.09%; hospitals hold 48.07% of 2025 application revenue while ambulatory surgical centers grow fastest at 11.03%; and hospital and institutional procurement still runs 55.1% of distribution revenue even as online and e-commerce channels, a far smaller base, grow fastest of any channel at 14.27%.
North America is the largest regional market, holding 37.5% of 2025 revenue (USD 1.66 billion) and reaching USD 3.27 billion by 2034; the United States alone accounts for USD 1.41 billion of that total, 32% of global revenue. Asia Pacific is the region gaining ground, climbing from 25.5% of revenue in 2025 to 30% by 2034 as its market grows from USD 1.12 billion to USD 2.8 billion. Middle East and Africa stays the smallest region throughout, edging from 4.2% to 4.5% of global revenue.
For 2034, the report sets a range around its base case. Faster reimbursement expansion for pneumatic devices, combined with a quicker rebound in elective surgical volumes, would lift revenue to USD 10.18 billion. Slower reimbursement growth, continued patient non-adherence, and softer surgical volumes would hold it to USD 8.5 billion. The base case of USD 9.34 billion sits between the two and anchors the report's central forecast.
The full report, "Compression Therapy Devices Market Size, Share & Industry Analysis, By Type, Product, Application, Indication, Distribution Channel, and Regional Forecast, 2026-2034," breaks the market into five segmentation axes with revenue and growth rates for every line from 2020 through 2034, covers all five regions at the country level, and includes the competitive landscape and research methodology behind each estimate. It is delivered as a PDF, with a free sample available on request.